Accelerated coronary atherosclerosis in cardiac allografts is the maior limiting factor for long-term survival after heart transplantation. There is growing evidence that activation of the coagulation mechanism is involved in the development of transplant atherosclerosis. Tissue factor (TF) expression by cells of the monocytelmacrophage system may represent an important mechanism underlying the fibrin deposition in the affected vessels. In the present study, we investigated the effect of cyclosporine A (CsA) on the lipopolysaccharide (LPS)-induced procoagulant activity (PCA) in human monocyteslmacrophages. CsA exerted a dose-dependent inhibitory effect on LPS-induced monocytelmacrophage PCA, which was identified as TF activity based on HE DEVELOPMENT OF a diffuse and progressive type T of occlusive coronary artery disease termed accelerated transplant atherosclerosis remains the leading limitation to long-term survival of cardiac transplant recipients, with a prevalence of about 45% at 3 years after transplantation.'-' Treatment of the transplant coronary artery disease is an unsolved clinical problem, because etiology and pathogenesis of this disease are still unknown.
T of occlusive coronary artery disease termed accelerated transplant atherosclerosis remains the leading limitation to long-term survival of cardiac transplant recipients, with a prevalence of about 45% at 3 years after transplantation.'-' Treatment of the transplant coronary artery disease is an unsolved clinical problem, because etiology and pathogenesis of this disease are still unknown.
Transplant vasculopathy seems to be a complex multifactorial event including activation of the immune and the coagulation ~y s t e m .~.~ Immunohistochemical studies indicate a gradual lesion development beginning with the adherence of monocytes7.* to the endothelial surface followed by fibrin deposition along the vascular intima,6 which may contribute to atherosclerotic plaque development.' Monocytes are able to initiate the coagulation cascade by expressing tissue factor (TF)-promoting fibrin deposition." Because of this procoagulant activity (PCA), they may play an important role in the pathogenesis of coronary lesions and represent the link between immunologic response and coagulation system in transplant atherosclerosis.
At present, cyclosporine A (CsA) is the immunosuppressive agent of choice. The introduction of CsA into transplant medicine has led to an improvement in graft and patient survival after heart transplantation.' ' Moreover, the drug has been suggested to decrease the incidence of graft coronary artery disease after human heart transplantati~n'~.'~ and to suppress experimental transplant ather~sclerosis.'~~'~ However, despite its successful use in transplant medicine for more than 20 years, the precise mechanism of the inhibitory action of CsA is still poorly understood. In view of monocyte/macrophage-mediated TF-dependent fibrin deposition, we investigated whether CsA influences the procoagulant activity generated by cells of the monocyte/macrophage Iineage.
Our data obtained in vitro give interesting information about a nonimmunomodulating effect of CsA. We found that CsA inhibits monocyte/macrophage TF induction by lipopolysaccharide (LPS) at both the transcriptional and functional levels. Analysis of the regulatory mechanism of the TF gene expression provides new insights into the molecular mechanisms of the action of the drug. 
MATERIALS AND METHODS
Human peripheral blood mononuclear (PBM) cells were isolated from buffy coats obtained from healthy blood donors by Ficoll-Hypaque density gradient centrifugation." PBM cells were further fractionated by adherence to plasma-coated tissue culture flasks. The isolated monocytes, suspended at a density of 1 X lo6 cells/mL in a defined serum-free culture medium (Monocyte SerumFree Medium [MSFM]; GIBCO BRL, Eggenstein, Germany), were plated in 30-mm 6-well culture plates (Greiner, Frickenhausen, Germany). The final cultures contained 90% to 95% monocytes, as evidenced by Pappenheim staining and fluorescence-activated cell sorting (FACS) analysis as well as nonspecific esterase staining of cytocentrifuge preparations. Cell viability was greater than 95% as determined by ethidiumbromide staining of cell aliquots and subsequent FACS analysis.
Cells were stimulated for 0 to 24 hours with LPS (Escherichia coli 0 1 11:B4; Sigma, Deisenhofen, Germany). To exclude any side effects of serum growth or coagulation factors, the incubation and stimulation of cells were performed in serum-free culture medium. Selected experiments were performed in the presence of 10% fetal bovine serum (FBS; GIBCO BRL).
Unstimulated cells were incubated without LPS under the same conditions. CsA (Sandoz, Basel, Switzerland; dissolved in polyoxethylated castor oil) was added to both stimulated and unstimulated cells at t = 0 hours at concentrations of 0.5, 1, 2, 5, and 10 pmoUL, respectively. For selected experiments, CsA was added before (24, 12, and 6 hours, respectively) or subsequent to (1, 2, 4, and 6 hours, respectively) the beginning of LPS stimulation. Controls were Cell culture.
Experimental protocol.
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performed by incubating the cells with the solvent in the absence of CsA. The experiments were terminated by pelleting and freezing the cells for later measurement of procoagulant activity.
PCA of cells, lysed by three freeze-thaw cycles, was measured using a one-stage clotting assay as described.lx Clotting times were converted to milliunits of PCA by reference to a standard curve established by serial dilutions of a standard rabbit brain thromboplastin preparation (Sigma). This standard curve (double logarithmic plot) was linear between 1 mU (122 seconds) and 1.000 mU (40 seconds). Values are given as milliunits per IO" cells. Medium or medium with reagents alone did not show any PCA. Factor VII-deficient plasma and monospecific antibody directed against human T F (American Diagnostica Inc, Greenwich, CT) was used to characterize the PCA as TF-like.
Ancdysis of total cellular protein synthesis. To determine whether CsA inhibits the protein synthesis rate, incorporation of phenylalanine into cells was measured by exposing cells to L-(U-'"C)-phenylalanine (0.1 pCi/mL) for 8 hours and measuring the rate of incorporation into the acid-insoluble cell mass. Nonradioactive phenylalanine (0.3 mmol/L) was included in the medium to minimize variations in the specific activity of the precursor pool responsible for protein synthesis. Experiments were terminated by the removal of the supematant medium from the cultures. After washing, icecold 10% (wt/vol) trichloroacetic acid (TCA) was added. After a storage overnight at 4"C, TCA was removed. Radioactivity contained in this acid fraction was taken to represent the intracellular precursor pool. Cultures were washed twice with ice-cold 10% (wt/vol) TCA and once with phosphate-buffered saline (PBS). The remaining precipitate was dissolved in 1 N NaOH 0.1 % (wthol) sodium dodecyl sulphate by incubation ovemight at 37°C. In these samples. DNA contents were determined photometrically'" and the radioactivity was counted. Flow cytometric analysis. To confirm immunofluorescencespecificity, LPS-induced T F expression was also examined by flow cyotmetric analysis. Cells were incubated with or without LPS, washed twice, and then fixed in cold (4°C) 1% formaldehyde in PBS for 30 minutes. Before fixation, aliquots of unstimulated and stimulated cells were analyzed for cell viability by ethidiumbromide staining. Consistently monocytes were viable to greater than 94%. as assessed by flow cytometric analysis. The fixed cells were incubated for 30 minutes at 4°C with an FITC-labeled murine antihuman T F MoAb (American Diagnostica Inc) for specific detection of TF expression. Identification of monocytes was performed by staining cells with a phycoerythrin (PE)-labeled mouse antihuman CD 14 MoAb (Becton Dickinson). Isotype control was performed using an irrelevant mouse antihuman 1gGl -FITC/lgG2a-PE antibody (Becton Dickinson). Cells were analyzed by flow cytometry using a FACSd'"' Measurement ofPCA.
flow cytometer (Becton Dickinson). Monocytes were gated according to their forward scatter and orthogonal light scatter characteristics.
Analysis of p65 protein in the cytoplasmatic and nuclear fraction of cells was performed by Western blotting. Cytoplasmatic and nuclear fractions were prepared essentially as described by Schreiber et al."' Twenty micrograms of cytophsmatic extracts or I O p& of nuclear extracts was separated onto 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, electroblotted o n ECL-Nitrocellulose membranes (AmershamBuchler. Braunschweig, Germany), and analyzed in Western blotting according to standard methods. Incubation with the primary antibody (anti-p65, 0.1 mg/mL diluted in TBS, 5% nonfatty dry milk. 0.05% Tween) was performed for 45 minutes at room temperature. After washing, the secondary antibody (horseradish peroxidase-coupled rabbit IgG. 1 :3,000) was added. Immunoreactive proteins were detected using the ECL-Wesrern Blot System (Amersham-Buchler) according to the manufacturer's instructions. Membranes were exposed to Hypertilm-ECL autoradiography films ( AmershaniBuchler) for 2 minutes.
RNA isolulion und wver.vc rrarzscriptas~-po~~~merase chuin reac'-riou (RT-PCR).
For isolation of total cellular RNA. the acid guanidinium thiocyanate-phenol-chloroform method was used as described by ChomcLynski and Sacchi." A total of 0.5 pg RNA was subjected to first-strand cDNA synthesis by preparing a master mix consisting of I X first-strand buffer (100 mmol/L Tris-HCI, pH 8. pmol/L of specific 5' and 3' primers, 0.75 U AmpliTaq DNA polymerase (Perkin Elmer). and 2 pL of first-strand cDNA. respectively, in a total volume of 25 pL. Sequences of intron spanning TF-specific primers were sense, 5' GCCGCCAACTGGTAGACATG 3'; and antisense. 5' TAGCCAGGATGATGACAAGG 3'; and for the housekeeping gene /?-actin, sense. 5' AAAGACCTGTACGCC-AACACAGTGCTGTCT 3': and antisense, 5' CGTCATACTCCT-GCTTGCTGATCCACATCTG 3', respectively. PCR profiles consisted of initial denaturation at 94°C for 1.5 minutes, followed by 25 cycles (p-actin) and 35 cycles (TF) of denaturation at 94°C for 50 seconds, primer annealing at 60°C (/?-actin) and 63°C (TF) for 35 seconds. and primer extension at 72°C for 30 seconds, respectively. The tinal primer extension was performed at 72°C for 7 minutes; subsequently. the reaction was chilled to 4°C. After RT-PCR, an aliquot of IS pL of the reaction mixture was electrophoresed through a 1.8% (wt/vol) Nusievehgarose gel and stained in an ethidiumbromide bath (Sigma). Negative controls were performed routinely by running PCR without cDNA to exclude false-positive a nplification products. The specificity of the obtained TF PCR products was verified by subjecting the related PCR product to automated DNA requencing (model 373A; Applied Biosystems. Uberlingen, Germany), essentially as dexribed by the manufacturer. and comparing the resultant cDNA sequence with the published human T F cDNA sequence.'' Nuclear extracts were prepared as described previously." The following oligonucleotides were labeled to a specific activity greater than S X IO' cpm/ p g DNA: NF-KB consensus, S'-AGTTGAGGGGACTTTCCC-AGGC-3': and TF-NF-KB. 5'-AGGGTCCCGGAGTTT CCTACC- In the two left columns, cells were treated with the indicated LPS doses for 8 GGGA-3'. NF-KB binding was performed in 10 mmol/L HEPES, pH 7.5, 0.5 mmol/L EDTA, 70 mmol/L KCl, 2 mmol/L D'IT, 2% glycerol, 0.025% NP-40, 4% Ficoll, 0.1 phenylmethyl sulfonyl fluoride, 1 mg/mL bovine serum albumin (DNAse free), and 0.1 pg/pL poly dl/dC in a total volume of 20 pL. For binding reactions to the TF-derived NF-KB site, the poly dWdC concentration was scaled up to 0.2 pg/pL. Ten micrograms of nuclear extracts was incubated for 20 minutes at room temperature in the presence of 1 ng labeled oligonucleotide (approximately 50,000 cpm Cerenkow). Protein-DNA complexes were separated from the free DNA probe by electrophoresis and autoradiographed as described previously in detail.24 Specificity of binding was ascertained by competition with a 160-fold molar excess of cold NF-KB consensus oligonucleotides and by characterization with monospecific antibodies directed against NF-KB family members (obtained from Santa Cruz Inc, Santa Cruz, CA; anti-p50 #sc-l14X, anti-p65 #sc-l09X, anti-c-re1 #sc-7OX, anti-relB #sc-226X, and anti-p52 #sc-298X).
Each experiment was performed in triplicate. Data are shown as the means 2 standard deviation (SD) of at least three separate experiments. Statistical significance was estimated with one-way analysis of variance (ANOVA) with pairwise contrasts by Scheffi. Differences were assumed to be statistically significant when P values were less than .05.
Statistics.
RESULTS
Stimulation of cells with LPS in serum-free culture medium resulted in a time-and dose-dependent induction of PCA (Table 1) . PCA reached the highest levels when incubated with 10 pg/ mL LPS for 8 hours. In the presence of serum, PCA of the the same order of magnitude (812 ? 23 mU/106 cells) was induced by 10 nglmL LPS. The LPS-induced PCA was due to TF activity because cell homogenates failed to shorten the clotting time of plasma deficient in factor VII. Furthermore, PCA was inhibited by the preincubation of monocytes/ macrophages with a monospecific antibody directed against human TF (Table 2) . Moreover, functional PCA in monocytes closely corresponds to antigenic TF expression on LPS-stimulated monocytes as evaluated by flow cytometry (data not shown).
Effect of CsA on monocyte/macrophage PCA.
Treatment of LPS-stimulated cells with CsA (0.5 to 10 pmoVL) inhibited the generation of PCA in a dose-dependent manner (Fig 1A) . A weak decrease in monocytelmacrophage PCA was induced already by 0.5 pmol/L CsA. CsA at concentrations of 1 and 2 pmol/L inhibited 30% and 70% of LPS-induced PCA, respectively, whereas doses of greater than 5 p m o K entirely abrogated the PCA response to LPS. Inhibition was observed independently of LPS treatment time periods (Fig 1B) . Preceeding as well as simultaneous addition of CsA to LPS-incubated cultures blocked monocytelmacrophage PCA. When CsA was added more than 2 hours after LPS, a reduction in inhibitory action was observed ( Fig 1C) . Treatment of resting cells with CsA did not alter the baseline PCA. CsA also inhibited LPS-induced (10 ng/mL; 8 hours) monocyte/macrophage PCA (50% inhibition at 1 p m o m CsA) in the presence of serum. The addition of the vehicle alone had no effect on PCA in either stimulated or unstimulated cells. The inhibitory effect of CsA was not due to an overall reduction of the total cellular protein synthetic rate of CsA-treated cells as evaluated by analysis of I4C-phenylalanine uptake by untreated and treated cells. In fact, no significant differences were observed in the I4C-phenylalanine uptake by cells treated with CsA versus control cells (107% ? 19% of control for 0.1 pmol/L CsA; 99% 2 20% of control for 5 p m o K CsA; and 105% t 19% of control for 10 pmol/L CsA). Moreover, concentrations of CsA used in the study ranging from 0.1 to 10 pmol/L did not show any toxic effect on cells, as evidenced by the measurement of lactate dehydrogenase activity of culture supernatants, by viability test of cells by ethidium bromide staining and subsequent FACS analysis (data not shown), 
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and by the absence of morphologic changes as observed by light microscopy. Effect of CsA on monocyte/macrophage TF antigen expression. TF expression in the presence of CsA was analyzed by immunofluorescence microscopy of monocytes/ macrophages grown on glass cover slips. Stimulation of cells with LPS (10 pg/mL) induced a strong, granular expression of TF antigen (Fig 2A) . Cells incubated with LPS in the presence of CsA (5 pmovL) showed a marked decrease in TF reactivity (Fig 2B) . Control cultures exposed to CsA alone did not show immunofluorescence reactivity by incubating cells with an irrelevant isotype control antibody. Unstimulated cells and cells exposed to CsA done were uni- formly negative with respect to TF expression by lacking specific immunoreactivity.
The effect of CsA on TF gene transcription was investigated using RT-PCR. Monocytes/macrophages were stimulated with LPS (10 pg/mL) in the presence or absence of CsA (5 pmoVL) and expression of mRNA for TF and p-actin was analyzed as described in the Materials and Methods. As shown in The CsA-induced suppression of TF gene transcription led us to investigate CsA-mediated alterations in the signal transduction cascade before TF gene transcription. EMSAs using NF-KB consensus (Fig 4A) and TF-derived NF-KB (Fig 4B) oligonucleotides were performed using nuclear extracts from monocytes/macrophages exposed to LPS in the presence or absence of CsA (5 pmoVL). In nuclear extracts of unstimuEffect of CsA on the binding activity of NF-KB. lated cells, moderate NF-KB consensus as well as TF-NF-KB binding activity was detected, whereas stimulation with LPS (10 pg/mL) effectively induced NF-KB activity. The addition of CsA (5 pmol/L) to cells stimulated with LPS decisively reduced NF-KB binding activity. Specificity of the binding reaction was shown by competition with unlabeled consensus oligonucleotides. Consistently, EMSA showed a CsA dependent reduction of the LPS-induced NF-KB -like complex, binding to the TF-derived NF-KB site (Fig 4B) . In accordance with previous reports, binding of this complex was reduced in the presence of anti-NF-~Bp65 and anti-c- 
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and slightly inhibited in the presence of anti-NF-~Bp52 antibodies, whereas antibodies to NF-~B p 5 0 and relB did not influence LPS-induced binding capacity (Fig 4C) . Supershifted bands with p65-and c-Relspecific antibodies became evident after longtime autoradiography (data not shown). Therefore, N F -K B~~~, c-Rel, and, to a lower extent, N F -K B~~~ contribute to the observed shift.
To analyze the CsA-mediated decrease in NF-KB activation in further detail, we performed Western blot analysis of the NF-KB p65 monomer in the nuclear and cytoplasmatic fraction of LPS/CsA-treated cells. In unstimulated (control) and CsAtreated cells (CsA), NF-KB p65 was detected in the cytoplasmatic, but not in the nuclear fraction. As shown in Fig  5, LPS stimulation induced the nuclear translocation of NF-KB p65 (LPS), which was inhibited when LPS stimulation (IO pg/mL) was performed in the presence of CsA (5 pmoll L) (LPS + CsA).
Effect of CsA on NF-KB nuclear translocation.
DISCUSSION
In the present study, CsA was shown to inhibit the induction of monocyte/macrophage PCA by decreasing LPS-mediated TF expression. T F inhibition was found to be caused by a reduced activation of the nuclear factor NF-KB, which is known to participate in T F gene expression. resulting in a decrease in T F mRNA transcription.
There is evidence that local fibrin deposition mediated by the expression of the procoagulant T F is one of the initial steps in transplant vascu1opathy.h' Cells of the monocyte/ macrophage lineage may represent the primary source of T F generation in the vascular bed of the transplanted heart. Therapeutical agents modulating monocyte/macrophage T F expression might therefore influence local fibrin deposition within the vessels of the graft.
Although the introduction of the immunosuppressant CsA into transplant medicine has led to an improvement in graft and patient survival after heart transplantation," the exact mechanism of the action has not yet been elucidated. Moreover, CsA has been suggested to decrease the incidence of graft coronary artery disease"." as well as to suppress experimental transplant atherosclerosis.'.l'S We hypothesized that nonimmunologic effects of CsA may contribute to its successful use in transplant medicine. Therefore, we investigated whether the generation of tissue factor in cells of the monocyte/macrophage system was influenced by the treatment with CsA.
CsA was shown to exert a dose-dependent inhibitory effect on both functional and antigeneic expression of LPSinduced monocyte/macrophage T F expression. Inhibition of T F activity by CsA was observed at concentrations neither affecting total protein synthesis nor being directly cytotoxic to the cells. Weak inhibition already appeared at nanomolar concentrations that are comparable to therapeutical levels used in transplant medicine. Concentrations inhibiting 50% to 100% of T F expression are similar to peak plasma levels that are reached after a single therapeutical CsA administration.'" Hence, CsA-mediated suppression of T F will be of pharmacologic relevance at concentrations that are transiently high during immunosuppressive therapy in clinical practice.
CsA has previously been shown by other investigators to either enhance?"33 or reduce"." monocyte/macrophage T F activity. Differences in cell isolation procedure, culture conditions, and particularly mode of stimulation may account for the diverging data concerning the effect of CsA on monocyte/macrophage T F activity. T F is known to be transiently inducible in monocyteslmacrophages by a variety of stimuli. including allogeneic mechanisms and bacterial LPS.""' ' ' ' In contrast to previous work, our experiments were performed in serum-free culture medium using LPS as stimulus. The modest amplification of T F activity in response to LPS under serum-free culture conditions in the present study is consistent with previous data showing that LPS-induced T F activity is several orders of magnitude lower in the absence than Stimulation of monocytes/macrophages with LPS, in turn, has been shown to induce activation of the transcription factor NF-KB.~'.'~ which is known to be required for TF gene as a direct immunmodulating agent, but also by influencing local coagulation activation by suppression of NF-KB.
transcripti~n.~~ This led us to investigate the NF-KB binding to a TF-derived NF-KB site and a T F consensus oligonucleotide. Treatment of cells with CsA markedly decreased LPSinduced binding activity of NF-KB. Further studies are required to determine whether enhanced inhibition of NF-KB binding activity by CsA in LPS-stimulated cells is due to predominance of NF-KB pSO/p6S heterodimers in stimulated cells or whether LPS stimulation affects other CsA-sensitive signaling pathways such as binding of CsA to its intracellular receptor protein as well as the interaction of immunophilin drug complexes and downstream signaling proteins. Although NF-KB was shown to be one of the possible targets of the inhibitory effect of CsA in the signal transduction pathway proximal to T F gene transcription, it cannot be ruled out that CsA exhibits similar effects on additional transcription factors not investigated in the present study. Further characterization of the suppressive effect of CsA on NF-KB activation showed an inhibitory effect on the nuclear translocation of NF-KB. These results indicate that CsA might prevent by a yet unidentified mechanism the LPSinduced dissociation of NF-KB from its inhibitor I-KB and therefore blocks the nuclear translocation of N F -K B .~~'
In conclusion, we have shown a dose-dependent inhibitory effect of CsA on monocyte/macrophage T F expression. CsA was shown to suppress the induction of T F gene transcription in activated monocyteslmacrophages by inhibiting the activation of the DNA-binding protein NF-KB. Our observations thus provide new insights into the still unknown molecular mechanisms by which CsA interferes with cellular activation pathways. Further investigations will be required to decide whether CsA provides a therapeutical tool acting not only For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From
